Overview
Laura Robelin practices in Strasbourg, France. Ms. Robelin is rated as an Experienced expert by MediFind in the treatment of Pseudobulbar Affect. Her top areas of expertise are Cerebellar Multiple System Atrophy, Primary Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), and Hereditary Ataxia.
Her clinical research consists of co-authoring 9 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Pseudobulbar Affect.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease)
- Cerebellar Multiple System AtrophyMs. Robelin isAdvanced. Learn about Cerebellar Multiple System Atrophy.
- Primary Lateral SclerosisMs. Robelin isAdvanced. Learn about Primary Lateral Sclerosis.
- Experienced
- Acute Cerebellar AtaxiaMs. Robelin isExperienced. Learn about Acute Cerebellar Ataxia.
- Drug Induced DyskinesiaMs. Robelin isExperienced. Learn about Drug Induced Dyskinesia.
- Familial DysautonomiaMs. Robelin isExperienced. Learn about Familial Dysautonomia.
- Hereditary AtaxiaMs. Robelin isExperienced. Learn about Hereditary Ataxia.
- Movement DisordersMs. Robelin isExperienced. Learn about Movement Disorders.
- Multiple System AtrophyMs. Robelin isExperienced. Learn about Multiple System Atrophy.